Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection

• Published in: Cancer prevention research (Philadelphia, Pa.) Pa.), 2017-11, Vol.10 (11), p.651-659
• Main Authors: Pavel, Ana B, Campbell, Joshua D, Liu, Gang, Elashoff, David, Dubinett, Steven, Smith, Kate, Whitney, Duncan, Lenburg, Marc E, Spira, Avrum
• Format: Article
• Language: English
• Subjects: Aged; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Bronchi - cytology; Bronchi - pathology; Bronchoscopy; Down-Regulation; Early Detection of Cancer - methods; Epithelial Cells - pathology; Female; Gene Expression Profiling - methods; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing - methods; Humans; Lung - pathology; Lung Neoplasms - diagnosis; Lung Neoplasms - etiology; Lung Neoplasms - genetics; Lung Neoplasms - pathology; Male; MicroRNAs - genetics; MicroRNAs - metabolism; Middle Aged; Oligonucleotide Array Sequence Analysis - methods; Prospective Studies; RNA, Messenger - genetics; RNA, Messenger - metabolism; ROC Curve; Sequence Analysis, RNA - methods; Smoking - adverse effects
• ISSN: 1940-6207; 1940-6215
• DOI: 10.1158/1940-6207.capr-17-0098

We have previously shown that gene expression alterations in normal-appearing bronchial epithelial cells can serve as a lung cancer detection biomarker in smokers. Given that miRNAs regulate airway gene expression responses to smoking, we evaluated whether miRNA expression is also altered in the bronchial epithelium of smokers with lung cancer. Using epithelial brushings from the mainstem bronchus of patients undergoing bronchoscopy for suspected lung cancer (as part of the AEGIS-1/2 clinical trials), we profiled miRNA expression via small-RNA sequencing from 347 current and former smokers for which gene expression data were also available. Patients were followed for one year postbronchoscopy until a final diagnosis of lung cancer ( = 194) or benign disease ( = 153) was made. Following removal of 6 low-quality samples, we used 138 patients (AEGIS-1) as a discovery set to identify four miRNAs (miR-146a-5p, miR-324-5p, miR-223-3p, and miR-223-5p) that were downregulated in the bronchial airway of lung cancer patients (ANOVA < 0.002, FDR < 0.2). The expression of these miRNAs is significantly more negatively correlated with the expression of their mRNA targets than with the expression of other nontarget genes (K-S < 0.05). Furthermore, these mRNA targets are enriched among genes whose expression is elevated in cancer patients (GSEA FDR < 0.001). Finally, we found that the addition of miR-146a-5p to an existing mRNA biomarker for lung cancer significantly improves its performance (AUC) in the 203 samples (AEGIS-1/2) serving an independent test set (DeLong < 0.05). Our findings suggest that there are miRNAs whose expression is altered in the cytologically normal bronchial epithelium of smokers with lung cancer, and that they may regulate cancer-associated gene expression differences. .